Posted on September 16th, 2014
Mr. Joyce is the founder, Chairman and Chief Executive Officer of Aethlon Medical.
Company OverviewAethlon Medical creates medical devices that target unmet therapeutic needs in infectious disease and cancer. The company's lead product is the Aethlon Hemopurifier®, a first-in-class device that selectively targets the rapid elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Exosome Sciences, Inc. is a majority owned subsidiary that is advancing exosome-based products to diagnose and monitor cancer, infectious disease and neurological disorders. Additional information can be found online at www.AethlonMedical.com. ... Learn More »
Over the weekend, the New York Times published a front-page article entitled; “Brain Trauma to Affect One in Three...Read More »
Posted on September 15th, 2014
It is my pleasure to introduce you to Targeted Medical Pharma (TRGM) with my first blog in a series of informative discu...Read More »
Posted on September 10th, 2014
Are pandemic viral pathogens establishing a global foothold? At present, the deadliest Ebola virus outbreak in history...Read More »
Posted on September 5th, 2014
Capstone Therapeutics Corp. (OTCQB: CAPS) is a “fallen angel,” reflected by the Company’s current market cap of $1...Read More »
Posted on September 4th, 2014
Strategic acquisitions have been the cornerstone of NeoStem’s growth and have been selected in order to provide value ...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »